Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma

被引:273
作者
Clark, David J. [1 ]
Dhanasekaran, Saravana M. [2 ]
Petralia, Francesca [3 ,4 ]
Pan, Jianbo [1 ]
Song, Xiaoyu [5 ,6 ]
Hu, Yingwei [1 ]
Leprevost, Felipe da Veiga [2 ]
Reva, Boris [3 ,4 ]
Lih, Tung-Shing M. [1 ]
Chang, Hui-Yin [2 ]
Ma, Weiping [3 ,4 ]
Huang, Chen [7 ]
Ricketts, Christopher J. [8 ]
Chen, Lijun [1 ]
Krek, Azra [3 ,4 ]
Li, Yize [9 ]
Rykunov, Dmitry [3 ,4 ]
Li, Qing Kay [1 ]
Chen, Lin S. [10 ]
Ozbek, Umut [5 ,6 ]
Vasaikar, Suhas [11 ]
Wu, Yige [9 ]
Yoo, Seungyeul [3 ,4 ]
Chowdhury, Shrabanti [3 ,4 ]
Wyczalkowski, Matthew A. [9 ]
Ji, Jiayi [5 ,6 ]
Schnaubelt, Michael [1 ]
Kong, Andy [2 ]
Sethuraman, Sunantha [9 ]
Avtonomov, Dmitry M. [2 ]
Ao, Minghui [1 ]
Colaprico, Antonio [12 ]
Cao, Song [9 ]
Cho, Kyung-Cho [1 ]
Kalayci, Selim [3 ,4 ]
Ma, Shiyong [1 ]
Liu, Wenke [13 ,14 ]
Ruggles, Kelly [15 ]
Calinawan, Anna [3 ,4 ]
Gumus, Zeynep H. [3 ,4 ]
Geizler, Daniel [16 ]
Kawaler, Emily [13 ,14 ]
Teo, Guo Ci [2 ]
Wen, Bo [7 ]
Zhang, Yuping [2 ]
Keegan, Sarah [13 ,14 ]
Li, Kai [7 ]
Chen, Feng [17 ,18 ]
Edwards, Nathan [19 ]
Pierorazio, Phillip M. [20 ,21 ]
机构
[1] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21231 USA
[2] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
[3] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA
[4] Icahn Sch Med Mt Sinai, Icahn Inst Data Sci & Genom Technol, New York, NY 10029 USA
[5] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA
[6] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA
[7] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA
[8] NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[9] Washington Univ, Sch Med, St Louis, MO 63110 USA
[10] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA
[11] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA
[12] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA
[13] NYU, Sch Med, Inst Syst Genet, New York, NY 10016 USA
[14] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA
[15] NYU, Sch Med, Dept Med, New York, NY 10016 USA
[16] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA
[17] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[18] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA
[19] Georgetown Univ, Dept Biochem & Cell Biol, Washington, DC 20007 USA
[20] Johns Hopkins Univ, Brady Urol Inst, Baltimore, MD 21231 USA
[21] Johns Hopkins Univ, Dept Urol, Baltimore, MD 21231 USA
[22] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA
[23] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10065 USA
[24] Poznan Univ Med Sci, Dept Urol, Szwajcarska 3, PL-61285 Poznan, Poland
[25] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[26] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, New York, NY 10065 USA
[27] Pomeranian Med Univ, Dept Genet & Pathol, PL-71252 Szczecin, Poland
[28] Int Inst Mol Oncol, PL-60203 Poznan, Poland
[29] Poznan Univ Med Sci, PL-60701 Poznan, Poland
[30] NCI, Off Canc Clin Prote Res, Bethesda, MD 20892 USA
[31] Frederick Natl Lab Canc Res, Frederick, MD 21702 USA
[32] Johns Hopkins Univ, Dept Ophthalmol, Baltimore, MD 21231 USA
[33] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[34] Sema4, Stamford, CT 06902 USA
[35] Univ Michigan, Dept Internal Med, Human Genet, Ann Arbor, MI 48109 USA
[36] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA
关键词
COMPREHENSIVE MOLECULAR CHARACTERIZATION; HYPOXIA-INDUCIBLE FACTORS; SET ENRICHMENT ANALYSIS; COPY NUMBER ALTERATION; FALSE DISCOVERY RATE; C-MYC; SIGNALING PATHWAYS; TUMOR-SUPPRESSOR; RIBOSOME BIOGENESIS; STATISTICAL-MODEL;
D O I
10.1016/j.cell.2019.10.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To elucidate the deregulated functional modules that drive clear cell renal cell carcinoma (ccRCC), we performed comprehensive genomic, epigenomic, transcriptomic, proteomic, and phosphoproteomic characterization of treatment-naive ccRCC and paired normal adjacent tissue samples. Genomic analyses identified a distinct molecular subgroup associated with genomic instability. Integration of proteogenomic measurements uniquely identified protein dysregulation of cellular mechanisms impacted by genomic alterations, including oxidative phosphorylation-related metabolism, protein translation processes, and phospho-signaling modules. To assess the degree of immune infiltration in individual tumors, we identified microenvironment cell signatures that delineated four immune-based ccRCC subtypes characterized by distinct cellular pathways. This study reports a large-scale proteogenomic analysis of ccRCC to discern the functional impact of genomic alterations and provides evidence for rational treatment selection stemming from ccRCC pathobiology.
引用
收藏
页码:964 / +
页数:51
相关论文
共 188 条
[1]   From big data analysis to personalized medicine for all: challenges and opportunities [J].
Alyass, Akram ;
Turcotte, Michelle ;
Meyre, David .
BMC MEDICAL GENOMICS, 2015, 8
[2]   Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies [J].
Anderson, Kristin G. ;
Stromnes, Ingunn M. ;
Greenberg, Philip D. .
CANCER CELL, 2017, 31 (03) :311-325
[3]  
[Anonymous], BIORXIV
[4]  
[Anonymous], 2016, NUCLEIC ACIDS RES, DOI DOI 10.1093/NAR/GKW550
[5]  
[Anonymous], J CLIN ONCOL
[6]  
[Anonymous], MOL CELL PROTEOMI S1
[7]  
[Anonymous], STAT SYST BIOL
[8]  
[Anonymous], 2016, F1000RESEARCH
[9]  
[Anonymous], J IMMUN RES
[10]  
[Anonymous], NEW ENGL J MED